Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups

Table 3

Brief characterization of the identified spots.

RCMD versus RA-RARS
Increase in RCMD			Increase in RA-RARS
Spot			Spot
8	0.00117	1.6	3	0.00002	2.3
15	0.00061	1.7	14	0.00534	1.6
—	—	—	17	0.00107	1.6
—	—	—	18	0.00093	1.6
RCMD versus RAEB-1
Increase in RCMD			Increase in RAEB-1
Spot			Spot
2	0.0032	1.8	1	0.00074	6.4
5	0.00382	1.6	12	0.00177	4.7
8	0.00011	2.0	13	0.00232	5.2
19	0.00124	1.6	14	0.00093	1.7
20	0.0035	1.5	16	0.00274	1.7
—	—	—	18	0.00519	1.6
RCMD versus RAEB-2
Increase in RCMD			Increase in RAEB-2
Spot			Spot
8	0.00392	1.6	6	0.00787	1.6
9	0.00335	1.6	7	0.00525	1.7
—	—	—	10	0.00659	1.6
—	—	—	18	0.00701	1.6
RA-RARS versus RAEB-2
Increase in RA-RARS			Increase in RAEB-2
Spot			Spot
3	0.00538	2.1	10	0.00435	1.8
4	0.00348	1.5	11	0.00104	1.6
9	0.00008	1.8	—	—	—

: -test value, : fold change value.